Kaplan-Meier survival analysis showed that the high CASP3 expression was associated with poor prognosis in ACC (p < 0.001, Figure 4H), LUAD (p = 0.029, Figure 4I), LGG (p = 0.001, Figure 4J), PRAD (p = 0.017, Figure 4K), and KIRP (p = 0.036, Figure 4L); high CASP3 expression was also associated with poor prognosis in sarcoma (SARC; p = 0.016, Figure 4M) and good prognosis in READ (p = 0.006, Figure 4N), COAD (p = 0.028, Figure 4O). The gene discussed is CASP3; the disease is reading.